Source: Market Cheetah

MedyMatch: MedyMatch to Demonstrate New Clinical Decision Support Platform for Detecting Intracranial Hemorrhage in Acute Care at RSNA 2017

CHICAGO, Nov. 26, 2017 /PRNewswire/ - Who: MedyMatch CEO Gene Saragnese and the MedyMatch team. What:Demonstrations: MedyMatch Technology, a leading artificial intelligence company delivering real-time clinical decision support in acute medical scenarios, will demonstrate...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Gene Saragnese's photo - Chairman & CEO of MedyMatch

Chairman & CEO

Gene Saragnese

CEO Approval Rating

50/100

Read more